Chronic Heart Failure and Coronary Artery Disease: Pharmacological Treatment and Cardiac Rehabilitation

Medicina (Kaunas). 2025 Jan 24;61(2):211. doi: 10.3390/medicina61020211.

Abstract

Coronary artery disease is the leading cause of acute and chronic heart failure. Patients with heart failure and ischemic heart disease need a tailored assessment to define the appropriate treatment, while a specific multidisciplinary management plan should be followed. Indeed, several factors should be assessed before starting treatment, such as heart failure symptoms and/or signs, angina, electrocardiographic features, right and left ventricular systolic and diastolic function, serological abnormalities, cardiac structural and functional integrity, and pulmonary function. New scenarios and developments have emerged recently in this field, increasing our knowledge regarding pathophysiology, exercise, and pharmacology. Effective and appropriate management and treatment reduce the risk of death and hospitalization for heart failure. Herein, we provide an updated, state-of-the-art overview of pharmacological treatment and cardiac rehabilitation in patients with chronic heart failure and coronary artery disease. Furthermore, tailored and contemporary management in clinical practice will be proposed for this specific and fragile patient population.

Keywords: cardiac rehabilitation; chronic heart failure; coronary artery disease; guideline-directed medical therapy; pharmacological treatment.

Publication types

  • Review

MeSH terms

  • Cardiac Rehabilitation* / methods
  • Chronic Disease
  • Coronary Artery Disease* / complications
  • Coronary Artery Disease* / drug therapy
  • Coronary Artery Disease* / physiopathology
  • Coronary Artery Disease* / rehabilitation
  • Heart Failure* / drug therapy
  • Heart Failure* / physiopathology
  • Heart Failure* / rehabilitation
  • Heart Failure* / therapy
  • Humans